» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

ROCKET PHARMACEUTICALS

WVB Number : USA000065987 Country : United States of America
SIC categorization : PHARMACEUTICAL PREPARATIONS (2834) ISIN : US77313F1066
FT categorization : HEALTH CARE (431)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is a multi-platform biotechnology company focused on the development of first-in-class gene therapies for rare and devastating pediatric diseases.
Phone : 1 302 636 5401 Fax : 781 6762155
Chairman: : GAURAV SHAH Auditor : EISNERAMPER LLP
CEO/Managing Director : GAURAV SHAH

» Company Facts

Net Profit Margin (%) N/A  
Operating Margin (%) N/A  
Return on Assets (%) -29.02  
Return on Equity (%) -34.46  
Employees 91  

» Company Financials

  Annual (2020)
Income Statement
('000 USD )
Sales/Total Revenue 0  
EBITDA -133,158  
EBIT -134,883  
Net Income -139,700  
Balance Sheet
( '000 USD)
Total Current Assets 487,345  
Total Assets 590,824  
Current Liabilities 32,617  
Total Liabilities & Debt 87,305  
Total Equity 503,519  
Cash & Flow
( '000 USD)
Net Income/Staring Line -139,700  
Cash from Operating -74,640  
Cash from Investing -96,591  
Cash from Financing 282,989  
Cash & Equivalent Yr End 298,666